These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 1597212)

  • 41. Glucuronidation of entacapone, nitecapone, tolcapone, and some other nitrocatechols by rat liver microsomes.
    Lautala P; Kivimaa M; Salomies H; Elovaara E; Taskinen J
    Pharm Res; 1997 Oct; 14(10):1444-8. PubMed ID: 9358559
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Activity of omeprazole on Helicobacter pylori and relation to toxicity of strains.
    Figura N; Armellini D; Bugnoli M; Bayeli PF; Gennari C; Crabtree JE
    J Clin Pathol; 1994 May; 47(5):440-2. PubMed ID: 8027398
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Role of gastric mucosal eicosanoid production in the cytoprotection induced by nitecapone.
    Aho PA; Lindén IB
    Scand J Gastroenterol; 1992; 27(2):134-8. PubMed ID: 1561527
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Additive effect of clarithromycin combined with 14-hydroxy clarithromycin, erythromycin, amoxycillin, metronidazole or omeprazole against Helicobacter pylori.
    Cederbrant G; Kahlmeter G; Schalén C; Kamme C
    J Antimicrob Chemother; 1994 Dec; 34(6):1025-9. PubMed ID: 7730216
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Sucralfate affects the susceptibility of Helicobacter pylori to antimicrobial agents.
    Slomiany BL; Piotrowski J; Majka J; Slomiany A
    Scand J Gastroenterol Suppl; 1995; 210():82-4. PubMed ID: 8578215
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [18F]-6-fluorodopa PET scanning in Parkinson's disease after selective COMT inhibition with nitecapone (OR-462).
    Laihinen A; Rinne JO; Rinne UK; Haaparanta M; Ruotsalainen U; Bergman J; Solin O
    Neurology; 1992 Jan; 42(1):199-203. PubMed ID: 1734304
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Bacteriostatic and bactericidal activity of rabeprazole against Helicobacter pylori.
    Garza-González E; Tijerina-Menchaca R; Pérez-Pérez GI; Bosques-Padilla FJ
    J Chemother; 2004 Dec; 16(6):612-3. PubMed ID: 15700857
    [No Abstract]   [Full Text] [Related]  

  • 48. Synergic interactions of macrolides and proton-pump inhibitors against Helicobacter pylori: a comparative in-vitro study.
    Malizia T; Tejada M; Marchetti F; Favini P; Pizzarelli G; Campa M; Senesi S
    J Antimicrob Chemother; 1998 Mar; 41 Suppl B():29-35. PubMed ID: 9579710
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Omeprazole may exert both a bacteriostatic and a bacteriocidal effect on the growth of Helicobacter pylori (NCTC 11637) in vitro by inhibiting bacterial urease activity.
    Mirshahi F; Fowler G; Patel A; Shaw G
    J Clin Pathol; 1998 Mar; 51(3):220-4. PubMed ID: 9659264
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Protection against alcohol-induced gastric mucosal injury by nitecapone.
    Slomiany BL; Piotrowski J; Ismail A; Rajiyah G; Tamura S; Bielanski W; Slomiany A
    Gen Pharmacol; 1991; 22(6):1055-62. PubMed ID: 1810804
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Nitecapone reduces cardiac neutrophil accumulation in clinical open heart surgery.
    Pesonen EJ; Vento AE; Rämo J; Vuorte J; Jansson SE; Repo H
    Anesthesiology; 1999 Aug; 91(2):355-61. PubMed ID: 10443596
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Protection by nitecapone against sodium taurocholate-induced damage to cultured gastric cells.
    Tu Y; Ranta S; Nissinen E; Lindén IB
    Dig Dis Sci; 1993 Apr; 38(4):701-7. PubMed ID: 7681749
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dopamine is metabolised by different enzymes along the rat nephron.
    Ibarra FR; Armando I; Nowicki S; Carranza A; De Luca Sarobe V; Arrizurieta EE; Barontini M
    Pflugers Arch; 2005 Jun; 450(3):185-91. PubMed ID: 15864503
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Interference on Helicobacter pylori growth and adhesion by omeprazole and other drugs.
    Gismondo MR; Drago L; Lombardi A; Fassina MC; Mombelli B
    J Chemother; 1998 Jun; 10(3):225-30. PubMed ID: 9669648
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Bactericidal activity and synergy studies of proton pump inhibitors and antibiotics against Helicobacter pylori in vitro.
    Midolo PD; Turnidge JD; Lambert JR
    J Antimicrob Chemother; 1997 Mar; 39(3):331-7. PubMed ID: 9096182
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of nitecapone and clorgyline, given intracerebro-ventricularly on L-dopa metabolism in the rat brain.
    Männistö PT; Törnwall M; Tuomainen P; Borisenko SA; Tuominen RK
    Neuroreport; 1992 Jul; 3(7):641-4. PubMed ID: 1421124
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The proton pump inhibitor omeprazole inhibits acid survival of Helicobacter pylori by a urease-independent mechanism.
    McGowan CC; Cover TL; Blaser MJ
    Gastroenterology; 1994 Nov; 107(5):1573-8. PubMed ID: 7926527
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Treatment regimens for Helicobacter pylori infection in children: is in vitro susceptibility testing helpful?
    Faber J; Bar-Meir M; Rudensky B; Schlesinger Y; Rachman E; Benenson S; Sirota G; Stankiewic H; Halle D; Wilschanski M
    J Pediatr Gastroenterol Nutr; 2005 May; 40(5):571-4. PubMed ID: 15861018
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of Drug Combination on Omeprazole Metabolism by Cytochrome P450 2C19 in Helicobacter pylori Eradication Therapy.
    Attia TZ; Yamashita T; Tsujino H; Derayea SM; Tsutsumi Y; Uno T
    Chem Pharm Bull (Tokyo); 2019; 67(8):810-815. PubMed ID: 31366830
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inhibitory activities of lansoprazole against respiration in Helicobacter pylori.
    Nagata K; Sone N; Tamura T
    Antimicrob Agents Chemother; 2001 May; 45(5):1522-7. PubMed ID: 11302821
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.